References

1. Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL et al. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008; 14(2): 1716232. PubMed | Google Scholar


2. Giancarlo Castaman. Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease. Mediterr J Hematol Infect Dis. 2013; 5(1): e2013052. PubMed | Google Scholar


3. Leissinger C, Carcao M, Gill JC, Journeycake J, Singleton T and Valentino L. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders. Haemophilia. 2014 Mar; 20(2): 158-67. PubMed | Google Scholar


4. Trigg DE, Stergiotou I, Peitsidis P and Kadir RA. A Systematic Review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. Haemophilia. 2012 Jan; 18(1): 25-33. PubMed | Google Scholar


5. Huq FY and Kadir RA. Management of pregnancy, labour and delivery in women with inherited bleeding disorders. Haemophilia. 2011; 17 (Suppl 1): 20-30. PubMed | Google Scholar


6. Stephen Choi, Richard Brull MD, MD, FRCPC. Neuraxial Techniques in Obstetric and Non-Obstetric Patients with Common Bleeding Diatheses. Anesth Analg. 2009 Aug;109(2):648-60. PubMed | Google Scholar